American Journal of Drug and Alcohol Abuse 2009;35:48-53. [doi: 10.1080/00952990802455444]
Jessica M. Peirce, PhD (Johns Hopkins University School of Medicine, MA Node), Nancy M. Petry, PhD (University of Connecticut School of Medicine), John M. Roll, PhD (University of California, Los Angeles, PR Node), Ken B. Kolodner, ScD (Johns Hopkins University School of Medicine, MA Node), Joseph Krasnansky, CSW (Lower Eastside Service Center, NY Node), Patricia Q. Stabile (Johns Hopkins University School of Medicine, MA Node), Chanda Brown, PhD, MSW (Charleston Center, SC Node), Maxine L. Stitzer, PhD (Johns Hopkins University School of Medicine, MA Node).
This study evaluated variables associated with stimulant use outcomes in stimulant users (N=800) receiving care in community outpatient psychosocial or methadone maintenance treatment clinics as part of CTN-0006 and CTN-0007 (Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics/Methadone Clinics). Results from the full sample were examined first, and then predictors were examined separately in the two treatment modalities. A cocaine-positive urine sample at study intake was the most robust and consistent correlate of stimulant use outcome in all analyses. Psychiatric distress, social environment and employment had differential effects on outcome across modalities. This secondary analysis confirms that intake assessments have considerable value in identifying problems to be addressed in treatment. (Article, Peer-Reviewed, PDF, English, 2009)
Keywords: Behavior therapy | Contingency Management (CM) | CTN platform/ancillary study | MIEDAR | Motivational incentives | Retention - Treatment | Stimulant abuse | American Journal of Drug and Alcohol Abuse (journal)
Document No: 338, PMID: 19152207, PMCID: PMC2722066
Submitted by CTN Dissemination Librarians, 1/20/2009.